Skip to main content

Month: June 2025

Whitestone REIT Declares Third Quarter 2025 Dividend

HOUSTON, June 10, 2025 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.045 per share on the Company’s common shares and operating partnership units for the third quarter of 2025.   The dividend represents a quarterly amount of $0.135 per share, and an annualized amount of $0.54 per share. The third quarter dividend distribution for 2025 will be as detailed below:Month Record Date Payment Date Distribution perShare/UnitJuly 7/1/2025 7/10/2025 $0.045August 8/1/2025 8/12/2025 $0.045September 9/2/2025 9/11/2025 $0.045       About Whitestone REIT Whitestone REIT (NYSE: WSR) is a community-centered real estate investment trust (REIT) that acquires, owns, operates, and develops open-air, retail centers...

Continue reading

OTC Markets Group Welcomes ATCO Ltd. to OTCQX

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ATCO Ltd. (TSX: ACO.X; OTCQX: ACLLF), a global enterprise provider of essential services in the energy, logistics and transportation, shelter, and real estate industries, has qualified to trade on the OTCQX® Best Market. ATCO Ltd. upgraded to OTCQX from the Pink® market. ATCO Ltd. begins trading today on OTCQX under the symbol “ACLLF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined...

Continue reading

Pharvaris Announces Annual Meeting of Shareholders

ZUG, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced the annual general meeting of shareholders will take place on Friday, June 27, 2025, at 16:00 CEST (10:00 a.m. EDT). All relevant documents and information relating to the annual general meeting, including the notice and agenda for the annual general meeting, are or will be made available in the “Investors” section of Pharvaris’ website under “Events & Presentations”. The documents will also be made available on the SEC’s website at www.sec.gov. Shareholders...

Continue reading

W&T Announces Appointment of Presiding Director for 2025

HOUSTON, June 10, 2025 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today announced that its Board of Directors (the “Board”) appointed Mr. John D. Buchanan as Presiding Director for 2025. He has served in that role since the 2024 Annual General Meeting and will continue as Presiding Director this year. Mr. Buchanan joined the Board in April 2024 and has more than 30 years of experience as a seasoned oil and gas, commercial and banking attorney, in addition to his prior service as a military officer. Tracy W. Krohn, W&T’s Chairman and Chief Executive Officer stated, “We are very pleased that our Board has named John as our continuing Presiding Director. That position serves a valuable leadership role on our Board and John’s extensive legal experience in the energy industry and banking...

Continue reading

Brown & Brown, Inc. enters into agreement to acquire Accession Risk Management Group

DAYTONA BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE: BRO), and John Mina, chief executive officer of Accession Risk Management Group, Inc. (“Accession”), today announced that Brown & Brown has entered into an agreement to acquire RSC Topco, Inc. (“RSC”), the holding company for Accession. The transaction is expected to close in the third quarter of 2025, subject to customary closing conditions and regulatory approvals. Under the terms of the agreement, Brown & Brown will acquire RSC on a cash and debt-free basis at the time of acquisition for a gross purchase price of $9.825 billion. The parties previously submitted filings in respect of the Transaction under the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,...

Continue reading

Dada Announces Shareholders’ Approval of Merger Agreement

SHANGHAI, China, June 10, 2025 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand retail and delivery platform, today announced that at an extraordinary general meeting of shareholders (the “EGM”) held today, the Company’s shareholders voted in favor of the proposal to authorize and approve the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated April 1, 2025, by and between the Company, JD Sunflower Investment Limited (“Parent”) and JD Sunflower Merger Sub Limited, a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, at the effective time of the merger, Merger Sub will merge with and into the Company and cease to exist, with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent,...

Continue reading

Form 8.3 – Spectris

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Jupiter Fund Management Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of Offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Spectris plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held:        For an opening position disclosure, state...

Continue reading

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that it is partnering with the Association of Pulmonary Advanced Practice Providers (APAPP) to bring new educational programs aimed at their professional membership to better provide access and timely care to patients at risk for lung cancer. In this novel partnership, the two organizations will launch new educational resources for Lung Health providers on innovative lung nodule risk assessment testing, such as the Nodify Lung® blood-based tests, or cancer treatment decision support testing, such as the IQLung® blood-based tests. According to the American...

Continue reading

Park Street A/S – total number of voting rights and capital resulting from the capital reduction

Park Street A/S Total number of voting rights and capital and changes in company’s treasury shares Park Street A/S – total number of voting rights and capital resulting from the capital reduction With reference to the company announcement on 28 April 2025 regarding the general meeting’s approval of a share capital reduction, Park Street A/S hereby announces that completion of the share capital reduction has been registered with the Danish Business Authority with effect on 10 June 2025. The cancellation of the 1,629,459 treasury A-shares (the listed shares) will be removed from trading on Nasdaq Copenhagen in the coming days.   The total nominal value of the share capital reduction is DKK 13,794,324 corresponding to 1,629,459 A-shares (listed) and 12,164,865 B-shares (not listed). Accordingly, Park Street A/S’ share capital...

Continue reading

Mullen Automotive Finalizes Settlement with GEM Group

Company moves forward accelerating its business objectives BREA, Calif. / NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, along with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS (together, “GEM”) today announces that they have finalized a settlement resolving all outstanding legal disputes between the parties. As part of the settlement, Mullen has transferred full, unencumbered ownership of its manufacturing facility located at 12900 McKinley Highway in Mishawaka, Indiana, to GEM. The transfer satisfies a federal court judgment in GEM’s favor. This settlement will resolve all related claims without further litigation and enables the Company to focus on forward-looking operational priorities. GEM’s acquisition...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.